Source: Annual Congress 2001 - Interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. D. Daniil, K. Malagari, J. Milic-Emili, C. Roussos, S. Papiris (Athens, Greece; Montreal, Canada). Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF). Eur Respir J 2001; 16: Suppl. 31, 1030

Member's Comments

No comment yet.

Related content which might interest you: Evaluating disease severity in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017 Year: 2017 Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Relationship between emphysema extent and pulmonary function test in chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Predictors of objective cough in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Similarities and differences between patients with chronic obstructive pulmonary disease and/or bronchiectasis Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Creatinine-height index, pulmonary function and dyspnoa in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Role of testosterone in acute exacerbation of chronic obstructive pulmonary disease: Relationship with severity indices Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Subjective symptoms and functional performances in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Nursing challenges at home and in hospital Year: 2009 Comparison of the different dyspnoea scales in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 1067-1072 Year: 2010 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007